{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:09:17Z","timestamp":1779926957542,"version":"3.53.1"},"reference-count":19,"publisher":"Informa Healthcare","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2012,7,1]]},"DOI":"10.1185\/03007995.2012.705264","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T11:25:05Z","timestamp":1340882705000},"page":"1155-1162","source":"Crossref","is-referenced-by-count":23,"title":["A retrospective analysis of therapy adherence in imatinib resistant or intolerant patients with chronic myeloid leukemia receiving nilotinib or dasatinib in a real-world setting"],"prefix":"10.1185","volume":"28","author":[{"given":"Annie","family":"Gu\u00e9rin","sequence":"first","affiliation":[{"name":"Analysis Group\rBoston, MAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation\rEast Hanover, NJUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Q.","family":"Wu","sequence":"additional","affiliation":[{"name":"Analysis Group\rBoston, MAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Ponce de Leon","sequence":"additional","affiliation":[{"name":"Analysis Group\rBoston, MAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute\rBoston, MAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2012,6,28]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-3-199908030-00008"},{"key":"CIT0002","unstructured":"Altekruse S, Kosary CL, Krapcho M et al. SEER Cancer Statistics Review. 2011. Available at: http:\/\/seer.cancer.gov\/csr\/1975_2007\/ [Last accessed 25 January 2012]"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-273979"},{"key":"CIT0004","unstructured":"ELN. Recommendations from the European LeukemiaNet for the Management of chronic myeloid leukemia (CML). Available at: http:\/\/www.leukemia-net.org\/content\/leukemias\/cml\/recommendations\/ [Last accessed 25 January 2012]"},{"key":"CIT0005","unstructured":"NCCN. NCCN Guidelines Version 2.2011 \u2013 Chronic Myelogenous Leukemia. NCCN Guidelines, 2011"},{"key":"CIT0006","unstructured":"US Food and Drug Administration: Dasatinib. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/021986s009s010lbl.pdf [Last accessed 9 May 2012]"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1097\/01.pra.0000344917.43780.77"},{"key":"CIT0008","unstructured":"US Food and Drug Administration: Nilotinib. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/022068s012lbl.pdf [Last accessed 9 May 2012]"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-196543"},{"key":"CIT0010","volume":"110","author":"Doti C","year":"2007","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3087"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-309807"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002315"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912614"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.649849"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.533648"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200725060-00004"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2006.00139.x"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08245.x"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/03007995.2012.705264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T04:28:37Z","timestamp":1597552117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/03007995.2012.705264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,28]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7,1]]}},"alternative-id":["10.1185\/03007995.2012.705264"],"URL":"https:\/\/doi.org\/10.1185\/03007995.2012.705264","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,28]]}}}